Prognostic and Predictive Model for Stage II Colon Cancer Patients With Nonemergent Surgery: Who Should Receive Adjuvant Chemotherapy?

No ideal prognostic model has been applied to clearly identify which suitable high-risk stage II colon cancer patients with negative margins undergoing nonemergent surgery should receive adjuvant chemotherapy routinely. Clinicopathologic and prognostic data of 333 stage II colon cancer patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chun-Dong, Wang, Ji-Nan, Sui, Bai-Qiang, Zeng, Yong-Ji, Chen, Jun-Qing, Dai, Dong-Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5304
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706247/
https://www.ncbi.nlm.nih.gov/pubmed/26735527
http://dx.doi.org/10.1097/MD.0000000000002190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706247/
https://www.ncbi.nlm.nih.gov/pubmed/26735527
http://dx.doi.org/10.1097/MD.0000000000002190

Ejemplares similares